FRIDAY, Sept. 12 (HealthDay News) -- International health experts will convene in New York City next week to discuss an unconventional and arguably radical approach to treating people with type 2 diabetes: weight-loss surgery.

These "bariatric" procedures are normally reserved for the morbidly obese, but recent studies suggest that patients with type 2 diabetes may benefit as well, by improving disease symptoms, often driving it into remission, and reducing the risk of death from the illness.

WASHINGTON (Reuters) - Morbidly obese patients who undergo weight-loss surgery greatly reduce their risk of cancer, according to a study providing fresh evidence of health benefits from these increasingly common operations.

Researchers from McGill University in Montreal found that the people who underwent bariatric surgery saw reductions in particular in the risk for breast and colon cancer. Many people see dramatic weight loss after such surgery.